ATLASPelthos Therapeutics (PTHS) earnings date: Nov 12, 2026
Pelthos Therapeutics (PTHS) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, before the open. Analysts expect EPS of -$2.83.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PTHS
| Last price | $9.40 (-43.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.6% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Pelthos Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Pelthos Therapeutics reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Pelthos Therapeutics. You can switch it off at any time.
Alert me before PTHS reportsFree to start. Creating an account takes under a minute.
PTHS earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$2.83 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -167.3% |
| Average move around a report | ±6.5% (last 5) |
| Sector | Healthcare · Biotechnology |
Pelthos Therapeutics earnings history: last 5 reports
Pelthos Therapeutics last reported on Aug 13, 2026: EPS of -$3.79 against an estimate of -$2.95 (-28.5% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$2.95 | -$3.79 | -28.5% | Miss | -4.9% |
| May 14, 2026 | -$3.58 | -$4.66 | -30.2% | Miss | +2.7% |
| Mar 19, 2026 | -$4.18 | -$2.69 | +35.7% | Beat | -13.9% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | +0.7% |
| Nov 13, 2025 | -$0.57 | -$5.30 | -829.8% | Miss | -10.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PTHS
See the fair value, the probability range and the earnings history of Pelthos Therapeutics on its ATLAS page.
Pelthos Therapeutics (PTHS) stock analysisPlans from €3.99 a month.
Pelthos Therapeutics earnings: frequently asked questions
When does Pelthos Therapeutics (PTHS) report earnings?
Pelthos Therapeutics is scheduled to report on Thursday, November 12, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PTHS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$2.83 per share (USD). Estimates can change before the report.
How often does PTHS beat earnings estimates?
Of its last 5 reports with a recorded result, Pelthos Therapeutics beat the EPS estimate 2 times; the average surprise was -167.3%. Past results do not predict the next one.
How much does PTHS move around earnings?
Over its last 5 reports the stock moved an average of 6.5% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Pelthos Therapeutics beat earnings estimates last quarter?
Pelthos Therapeutics last reported on Aug 13, 2026: EPS of -$3.79 against an estimate of -$2.95 (-28.5% surprise), a miss.
How much does PTHS usually move in a day?
On a normal trading day the ATLAS model puts PTHS’s one-day range at about ±10.6%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer